Yarrow Bioscience Inc (YARW) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Yarrow Bioscience Inc (YARW) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $636,252, listed on NASDAQ, employing roughly 10 people, carrying a beta of 2.02 to the broader market. Yarrow Bioscience is a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases. Led by Rebecca Velez Frey, public since 2026-07-28.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for YARW as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →